| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TYRA | Common Stock | Sale | $113,097 | -6,944 | -0.19% | $16.29 | 3,724,221 | 16 Jan 2025 | By Canaan XI L.P. | F1, F2 |
| transaction | TYRA | Common Stock | Sale | $13,600 | -835 | -0.19% | $16.29 | 447,857 | 16 Jan 2025 | By 2020+ Co-Investment L.P. - Series 7 | F1, F3 |
| transaction | TYRA | Common Stock | Sale | $210,052 | -12,808 | -0.34% | $16.40 | 3,711,413 | 17 Jan 2025 | By Canaan XI L.P. | F2, F4 |
| transaction | TYRA | Common Stock | Sale | $7,560 | -461 | -0.1% | $16.40 | 447,396 | 17 Jan 2025 | By 2020+ Co-Investment L.P. - Series 7 | F3, F4 |
| transaction | TYRA | Common Stock | Sale | $65,336 | -3,993 | -0.11% | $16.36 | 3,707,420 | 21 Jan 2025 | By Canaan XI L.P | F2, F5 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.25 to $16.64. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F2 | The sole general partner of Canaan XI L.P. ("Canaan XI") is Canaan Partners XI LLC ("Canaan XI GP"), which may be deemed to have sole voting, investment and dispositive power with respect to the shares held by Canaan XI. Canaan XI GP disclaims Section 16 beneficial ownership of the securities held by Canaan XI, except to the extent of its pecuniary interest therein, if any. |
| F3 | The sole general partner of Canaan 2020+ Co-Investment L.P. - Series 7 (the "Canaan Series 7") is Canaan Partners 2020+ Co-Investment LLC ("Canaan 2020+ GP"), which may be deemed to have sole voting, investment and dispositive power with respect to the shares held by Canaan Series 7. Canaan 2020+ GP disclaims Section 16 beneficial ownership of the securities held by Canaan Series 7, except to the extent of its pecuniary interest therein, if any. |
| F4 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.25 to $16.59. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F5 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.25 to $16.58. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
Exhibit 24.2 Power of Attorney